Patents by Inventor Mette Grønborg

Mette Grønborg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic use of a growth factor, NsG33
    Patent number: 9845344
    Abstract: The present invention relates to the field of therapeutic use of proteins, genes and cells. More specifically the invention relates to therapy based on the biological function of a secreted therapeutic protein, NsG33, in particular for the treatment of disorders of the nervous system. NsG33 is a nerve survival and growth factor with antiapoptotic effects on a cell line with neuronal potential and with neuroprotective and/or neurogenesis effects on a neural precursor cell line and on primary striatal cultures. The invention also relates to novel bioactive NsG33 polypeptide fragments and the corresponding encoding DNA sequences.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: December 19, 2017
    Assignee: HOBA THERAPEUTICS APS
    Inventors: Mette Grønborg, Philip Kusk, Nikolaj Blom, Thomas Nordahl Petersen, Teit E. Johansen, Søren Brunak, Lars U. Wahlberg
  • THERAPEUTIC USE OF A GROWTH FACTOR, NSG33
    Publication number: 20120184492
    Abstract: The present invention relates to the field of therapeutic use of proteins, genes and cells. More specifically the invention relates to therapy based on the biological function of a secreted therapeutic protein, NsG33, in particular for the treatment of disorders of the nervous system. NsG33 is a nerve survival and growth factor with antiapoptotic effects on a cell line with neuronal potential and with neuroprotective and/or neurogenesis effects on a neural precursor cell line and on primary striatal cultures. The invention also relates to novel bioactive NsG33 polypeptide fragments and the corresponding encoding DNA sequences.
    Type: Application
    Filed: December 15, 2011
    Publication date: July 19, 2012
    Applicant: NsGene A/S
    Inventors: Mette Grønborg, Philip Kusk, Nikolaj Blom, Thomas Nordahl Petersen, Teit E. Johansen, Soren Brunak, Lars U. Wahlberg
  • Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
    Patent number: 6576641
    Abstract: The present invention relates to certain fused heterocyclic compounds (I) and their use in the treatment of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons.
    Type: Grant
    Filed: June 7, 2001
    Date of Patent: June 10, 2003
    Assignee: Neurosearch A/S
    Inventors: Dan Peters, Mette Grønborg, Arne Møller